Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface

Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface

Neuronal damage secondary to traumatic brain injury (TBI) is a rapidly evolving condition, which requires therapeutic decisions based on the timely identification of clinical deterioration. Changes in S100B biomarker levels are associated with TBI severity and patient outcome. The S100B quantificati...

Full description

Bibliographic Details
Main Authors: Alexander Rodríguez, Francisco Burgos-Flórez, José D. Posada, Eliana Cervera, Valtencir Zucolotto, Homero Sanjuán, Marco Sanjuán, Pedro J. Villalba
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Sensors
Subjects:
biosensor
gold electrodes
electrochemical impedance spectroscopy
brain injuries
S-100B
biomarker
Online Access:https://www.mdpi.com/1424-8220/21/6/1929

Internet

https://www.mdpi.com/1424-8220/21/6/1929

Similar Items